Investor Overview

KindredBio is focused on bringing breakthrough human products and innovative new technologies to veterinary medicine to address unmet clinical needs and provide benefits to animal co... 

Stock Information

Change (%) - 0.19 (1.45%)
Data as of 10/19/18 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.


Kindred Biosciences to Present at Cantor Global Healthcare Conference and Ladenburg Thalmann 2018 Healthcare Conference

September 17, 2018

SAN FRANCISCO, Sept. 17, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences to Participate in the B. Riley FBR Annual Healthcare Conference

August 21, 2018

SAN FRANCISCO, Aug. 21, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...